Christoph Lawrence Bausch insider trades
Open-market stock purchases and sales by Christoph Lawrence Bausch, CHIEF OPERATING OFFICER at SAB Biotherapeutics, Inc, from SEC Form 4 filings since Oct 22, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 3, 2026 | SABS SAB Biotherapeutics, Inc | Bought (not open market) | — |
Companies traded
- SABS SAB Biotherapeutics, Inc: other filings, last Feb 3, 2026
Get free alerts when Christoph Lawrence Bausch files a new trade →